{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:09Z","timestamp":1786980069106,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00383-019-04568-0","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T07:23:17Z","timestamp":1569396197000},"page":"1403-1411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhanced metastatic growth after local tumor resection in the presence of synchronous metastasis in a mouse allograft model of neuroblastoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Maho","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Inokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnosuke","family":"Maniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Fumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"issue":"14","key":"4568_CR1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","volume":"363","author":"AL Yu","year":"2010","unstructured":"Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM, Children\u2019s Oncology G (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363(14):1324\u20131334. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0911123","journal-title":"N Engl J Med"},{"issue":"10","key":"4568_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/s1470-2045(13)70309-7","volume":"14","author":"SG Kreissman","year":"2013","unstructured":"Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, LaQuaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG (2013) Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol 14(10):999\u20131008. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(13)70309-7","journal-title":"Lancet Oncol"},{"issue":"5","key":"4568_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10147-018-1281-8","volume":"23","author":"Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A, Japan Childhood Cancer Group Neuroblastoma C","year":"2018","unstructured":"Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A, Japan Childhood Cancer Group Neuroblastoma C (2018) Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Int J Clin Oncol 23(5):965\u2013973. \n                    https:\/\/doi.org\/10.1007\/s10147-018-1281-8","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"4568_CR4","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","volume":"77","author":"S Tohme","year":"2017","unstructured":"Tohme S, Simmons RL, Tsung A (2017) Surgery for Cancer: a Trigger for Metastases. Cancer Res 77(7):1548\u20131552. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1536","journal-title":"Cancer Res"},{"issue":"4","key":"4568_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10585-018-9896-8","volume":"35","author":"M Alieva","year":"2018","unstructured":"Alieva M, van Rheenen J, Broekman MLD (2018) Potential impact of invasive surgical procedures on primary tumor growth and metastasis. Clin Exp Metastasis 35(4):319\u2013331. \n                    https:\/\/doi.org\/10.1007\/s10585-018-9896-8","journal-title":"Clin Exp Metastasis"},{"issue":"9","key":"4568_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00383-009-2417-8","volume":"25","author":"SB Moon","year":"2009","unstructured":"Moon SB, Park KW, Jung SE, Youn WJ (2009) Neuroblastoma: treatment outcome after incomplete resection of primary tumors. Pediatr Surg Int 25(9):789\u2013793. \n                    https:\/\/doi.org\/10.1007\/s00383-009-2417-8","journal-title":"Pediatr Surg Int"},{"issue":"6","key":"4568_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jpedsurg.2004.02.041","volume":"39","author":"ES Adkins","year":"2004","unstructured":"Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM (2004) Efficacy of complete resection for high-risk neuroblastoma: a Children\u2019s Cancer Group study. J Pediatr Surg 39(6):931\u2013936. \n                    https:\/\/doi.org\/10.1016\/j.jpedsurg.2004.02.041","journal-title":"J Pediatr Surg"},{"issue":"3","key":"4568_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jpedsurg.2003.11.028","volume":"39","author":"MP La Quaglia","year":"2004","unstructured":"La Quaglia MP, Kushner BH, Su W, Heller G, Kramer K, Abramson S, Rosen N, Wolden S, Cheung NK (2004) The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 39(3):412\u2013417. \n                    https:\/\/doi.org\/10.1016\/j.jpedsurg.2003.11.028","journal-title":"J Pediatr Surg"},{"issue":"4","key":"4568_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpedsurg.2013.11.061","volume":"49","author":"L Du","year":"2014","unstructured":"Du L, Liu L, Zhang C, Cai W, Wu Y, Wang J, Lv F (2014) Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy. J Pediatr Surg 49(4):528\u2013533. \n                    https:\/\/doi.org\/10.1016\/j.jpedsurg.2013.11.061","journal-title":"J Pediatr Surg"},{"issue":"11","key":"4568_CR10","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","volume":"16","author":"WA Weiss","year":"1997","unstructured":"Weiss WA, Mohapatra G, Feuerstein BG, Bishop JM (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16(11):2985\u20132995. \n                    https:\/\/doi.org\/10.1093\/emboj\/16.11.2985","journal-title":"EMBO J"},{"issue":"12","key":"4568_CR11","doi-asserted-by":"publisher","first-page":"e51297","DOI":"10.1371\/journal.pone.0051297","volume":"7","author":"A Rasmuson","year":"2012","unstructured":"Rasmuson A, Segerstrom L, Nethander M, Finnman J, Elfman LH, Javanmardi N, Nilsson S, Johnsen JI, Martinsson T, Kogner P (2012) Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma. PLoS One 7(12):e51297. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0051297","journal-title":"PLoS One"},{"issue":"1","key":"4568_CR12","doi-asserted-by":"publisher","first-page":"e1003996","DOI":"10.1371\/journal.pgen.1003996","volume":"10","author":"Y Suenaga","year":"2014","unstructured":"Suenaga Y, Islam SM, Alagu J, Kaneko Y, Kato M, Tanaka Y, Kawana H, Hossain S, Matsumoto D, Yamamoto M, Shoji W, Itami M, Shibata T, Nakamura Y, Ohira M, Haraguchi S, Takatori A, Nakagawara A (2014) NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3beta resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet 10(1):e1003996. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1003996","journal-title":"PLoS Genet"},{"issue":"1","key":"4568_CR13","doi-asserted-by":"publisher","first-page":"e86813","DOI":"10.1371\/journal.pone.0086813","volume":"9","author":"D Cao","year":"2014","unstructured":"Cao D, Kishida S, Huang P, Mu P, Tsubota S, Mizuno M, Kadomatsu K (2014) A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model. PLoS One 9(1):e86813. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0086813","journal-title":"PLoS One"},{"issue":"19","key":"4568_CR14","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-16-3144","volume":"77","author":"S Tsubota","year":"2017","unstructured":"Tsubota S, Kishida S, Shimamura T, Ohira M, Yamashita S, Cao D, Kiyonari S, Ushijima T, Kadomatsu K (2017) PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma. Cancer Res 77(19):5259\u20135271. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3144","journal-title":"Cancer Res"},{"issue":"8","key":"4568_CR15","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1158\/0008-5472.CAN-10-3524","volume":"71","author":"P Huang","year":"2011","unstructured":"Huang P, Kishida S, Cao D, Murakami-Tonami Y, Mu P, Nakaguro M, Koide N, Takeuchi I, Onishi A, Kadomatsu K (2011) The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma. Cancer Res 71(8):2938\u20132948. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3524","journal-title":"Cancer Res"},{"issue":"13","key":"4568_CR16","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-12-2681","volume":"73","author":"T Teitz","year":"2013","unstructured":"Teitz T, Inoue M, Valentine MB, Zhu K, Rehg JE, Zhao W, Finkelstein D, Wang YD, Johnson MD, Calabrese C, Rubinstein M, Hakem R, Weiss WA, Lahti JM (2013) Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis. Cancer Res 73(13):4086\u20134097. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2681","journal-title":"Cancer Res"},{"key":"4568_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-741","author":"J t\u2019 Lam-Boer","year":"2014","unstructured":"t\u2019 Lam-Boer J, Verhoef C, de Haan AF, Yilmaz M, Punt CJ, Wilt JH, Koopman M (2014) The CAIRO4 study the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer\u2013a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG). BMC Cancer. \n                    https:\/\/doi.org\/10.1186\/1471-2407-14-741","journal-title":"BMC Cancer"},{"issue":"3","key":"4568_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11605-017-3617-5","volume":"22","author":"S Maroney","year":"2018","unstructured":"Maroney S, de Paz CC, Reeves ME, Garberoglio C, Raskin E, Senthil M, Namm JP, Solomon N (2018) Benefit of surgical resection of the primary tumor in patients undergoing chemotherapy for stage iv colorectal cancer with unresected metastasis. J Gastrointest Surg 22(3):460\u2013466. \n                    https:\/\/doi.org\/10.1007\/s11605-017-3617-5","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"4568_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10549-008-0032-3","volume":"114","author":"S Amar","year":"2009","unstructured":"Amar S, Roy V, Perez EA (2009) Treatment of metastatic breast cancer: looking towards the future. Breast Cancer Res Treat 114(3):413\u2013422. \n                    https:\/\/doi.org\/10.1007\/s10549-008-0032-3","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"4568_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/sj.bjc.6604640","volume":"99","author":"De Bernardi B, Mosseri V, Rubie H, Castel V, Foot A, Ladenstein R, Laureys G, Beck-Popovic M, de Lacerda AF, Pearson AD, De Kraker J, Ambros PF, de Rycke Y, Conte M, Bruzzi P, Michon J, Group SEN","year":"2008","unstructured":"De Bernardi B, Mosseri V, Rubie H, Castel V, Foot A, Ladenstein R, Laureys G, Beck-Popovic M, de Lacerda AF, Pearson AD, De Kraker J, Ambros PF, de Rycke Y, Conte M, Bruzzi P, Michon J, Group SEN (2008) Treatment of localised resectable neuroblastoma Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer 99(7):1027\u20131033. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6604640","journal-title":"Br J Cancer"},{"issue":"1","key":"4568_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejca.2008.09.016","volume":"45","author":"S Modak","year":"2009","unstructured":"Modak S, Kushner BH, LaQuaglia MP, Kramer K, Cheung NK (2009) Management and outcome of stage 3 neuroblastoma. Eur J Cancer 45(1):90\u201398. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2008.09.016","journal-title":"Eur J Cancer"},{"issue":"2","key":"4568_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2012.05.021","volume":"324","author":"P Chiarella","year":"2012","unstructured":"Chiarella P, Bruzzo J, Meiss RP, Ruggiero RA (2012) Concomitant tumor resistance. Cancer Lett 324(2):133\u2013141. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2012.05.021","journal-title":"Cancer Lett"},{"issue":"2","key":"4568_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/bjc.1996.335","volume":"74","author":"MBO Franco","year":"1996","unstructured":"Franco MBO, di Gianni PD, Goldman A, Pasqualini CD, Ruggiero RA (1996) A serum-mediated mechanism for concomitant resistance shared by immnogenic and non-immnogenic murine tumors. Br J Cancer 74(2):178\u2013186. \n                    https:\/\/doi.org\/10.1038\/bjc.1996.335","journal-title":"Br J Cancer"},{"issue":"22","key":"4568_CR24","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1158\/0008-5472.CAN-11-0581","volume":"71","author":"RA Ruggiero","year":"2011","unstructured":"Ruggiero RA, Bruzzo J, Chiarella P, di Gianni P, Isturiz MA, Linskens S, Speziale N, Meiss RP, Bustuoabad OD, Pasqualini CD (2011) Tyrosine isomers mediate the classical phenomenon of concomitant tumor resistance. Cancer Res 71(22):7113\u20137124. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0581","journal-title":"Cancer Res"},{"key":"4568_CR25","unstructured":"Ehrlich P, Apolant H (1906) Experimentelle carcinomstudien an M\u00e4usen. Arbeiten aus dem Koiglichen Institut fur Experimentelle Therapie zu Frankfurt\/AM. Jena, Germany. Gustav Fischer"},{"issue":"9","key":"4568_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/annonc\/mdi280","volume":"16","author":"R Demicheli","year":"2005","unstructured":"Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJ, Retsky MW, Valagussa P, Bonadonna G (2005) Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol 16(9):1449\u20131457. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdi280","journal-title":"Ann Oncol"},{"issue":"1","key":"4568_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1302\/0301-620x.86b1.14069","volume":"86-B","author":"M Kaya","year":"2004","unstructured":"Kaya M, Wada T, Nagoya S, Kawaguchi S, Isu K, Yamashita T (2004) Concomitant tumour resistance in patients with osteosarcoma. J Bone Joint Surg British 86-B(1):143\u2013147. \n                    https:\/\/doi.org\/10.1302\/0301-620x.86b1.14069","journal-title":"J Bone Joint Surg British"},{"key":"4568_CR28","first-page":"69","volume":"3","author":"E Bashford","year":"1910","unstructured":"Bashford E (1910) The immunity reaction to cancer. Proc R Soc Med 3:69\u201381","journal-title":"Proc R Soc Med"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-019-04568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-019-04568-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-019-04568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T21:37:50Z","timestamp":1600897070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-019-04568-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4568"],"URL":"https:\/\/doi.org\/10.1007\/s00383-019-04568-0","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"12 September 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}